185 related articles for article (PubMed ID: 21539605)
1. Treatment of oral squamous cell carcinoma with accelerated radiation therapy and concomitant carboplatin in cats.
Fidel J; Lyons J; Tripp C; Houston R; Wheeler B; Ruiz A
J Vet Intern Med; 2011; 25(3):504-10. PubMed ID: 21539605
[TBL] [Abstract][Full Text] [Related]
2. Palliative radiation therapy outcomes for cats with oral squamous cell carcinoma (1999-2005).
Sabhlok A; Ayl R
Vet Radiol Ultrasound; 2014; 55(5):565-70. PubMed ID: 24766180
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of an accelerated hypofractionated radiation therapy protocol in cats with oral squamous cell carcinoma.
Poirier VJ; Kaser-Hotz B; Vail DM; Straw RC
Vet Radiol Ultrasound; 2013; 54(1):81-8. PubMed ID: 23078236
[TBL] [Abstract][Full Text] [Related]
4. A nine-day accelerated radiation protocol for feline squamous cell carcinoma.
Fidel JL; Sellon RK; Houston RK; Wheeler BA
Vet Radiol Ultrasound; 2007; 48(5):482-5. PubMed ID: 17899987
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma.
Jones PD; de Lorimier LP; Kitchell BE; Losonsky JM
J Am Anim Hosp Assoc; 2003; 39(5):463-7. PubMed ID: 14518654
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats.
Théon AP; VanVechten MK; Madewell BR
Am J Vet Res; 1996 Feb; 57(2):205-10. PubMed ID: 8633809
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an Accelerated Chemoradiotherapy Protocol for Oropharyngeal Squamous Cell Carcinoma in 5 Cats and 3 Dogs.
Rejec A; Benoit J; Tutt C; Crossley D; Butinar J; Hren NI
J Vet Dent; 2015; 32(4):212-21. PubMed ID: 27012058
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and outcome in cats with oral squamous cell carcinoma after accelerated hypofractionated radiotherapy and concurrent systemic treatment.
Marconato L; Weyland M; Tresch N; Rossi F; Leone V; Rohrer Bley C
Vet Comp Oncol; 2020 Sep; 18(3):362-369. PubMed ID: 31756259
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
Olmsted GA; Farrelly J; Post GS; Smith J
J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
[TBL] [Abstract][Full Text] [Related]
10. Response of feline oral squamous cell carcinoma to palliative radiation therapy.
Bregazzi VS; LaRue SM; Powers BE; Fettman MJ; Ogilvie GK; Withrow SJ
Vet Radiol Ultrasound; 2001; 42(1):77-9. PubMed ID: 11245242
[TBL] [Abstract][Full Text] [Related]
11. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
Fox LE; Rosenthal RC; King RR; Levine PB; Vail DM; Helfand SC; MacEwen EG; Perez-Soler R; Calderwood-Mays M; Kurzman ID
Am J Vet Res; 2000 Jul; 61(7):791-5. PubMed ID: 10895902
[TBL] [Abstract][Full Text] [Related]
12. Computed tomographic features of oral squamous cell carcinoma in cats: 18 cases (2002-2008).
Gendler A; Lewis JR; Reetz JA; Schwarz T
J Am Vet Med Assoc; 2010 Feb; 236(3):319-25. PubMed ID: 20113245
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
14. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006).
Hammond GM; Gordon IK; Theon AP; Kent MS
J Am Vet Med Assoc; 2007 Sep; 231(5):736-41. PubMed ID: 17764434
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of plasma folate and homocysteine concentrations in cats with and without oral squamous cell carcinoma.
Fulmer AK; Mauldin GE; Mauldin GN
Vet Comp Oncol; 2008 Dec; 6(4):248-56. PubMed ID: 19178683
[TBL] [Abstract][Full Text] [Related]
17. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
[TBL] [Abstract][Full Text] [Related]
18. Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review.
Bilgic O; Duda L; Sánchez MD; Lewis JR
J Vet Dent; 2015; 32(1):30-40. PubMed ID: 26197688
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
